Internal Medicine · Oakland, CA
NPI
1235300658
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
424 28th St
Oakland, CA, 94609
Phone (510) 452-4824
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$445K
9,142 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Kevin Chen prescribed most often to Medicare patients was Atorvastatin Calcium, with 721 prescriptions and refills. In total Kevin Chen wrote 9,142 Medicare prescriptions that cost $445K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-15.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 721 | 2,343 | 253 | $8,625 |
| Amlodipine Besylate Generic | 441 | 1,447 | 158 | $5,603 |
| Lisinopril Generic | 364 | 1,206 | 126 | $4,317 |
| Losartan Potassium Generic | 330 | 1,092 | 117 | $4,161 |
| Levothyroxine Sodium Generic | 307 | 920 | 100 | $5,924 |
| Simvastatin Generic | 250 | 777 | 78 | $2,890 |
| Tamsulosin Hcl Generic | 227 | 687 | 78 | $3,876 |
| Metformin Hcl Er Metformin Hcl | 184 | 602 | 64 | $1,576 |
| Atenolol Generic | 181 | 599 | 64 | $2,241 |
| Gabapentin Generic | 166 | 456 | 70 | $3,259 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 149 | 149 | 28 | $4,091 |
| Metoprolol Succinate Generic | 140 | 453 | 51 | $1,662 |
| Famotidine Generic | 133 | 400 | 53 | $1,637 |
| Furosemide Generic | 131 | 321 | 44 | $1,440 |
| Fluticasone Propionate Generic | 126 | 153 | 55 | $2,763 |
Brand drugs: 835 claims; generic drugs: 8,246 claims; opioid claims: 289.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kevin Chen were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.